| Submission of formal petitions and representations to PMDA [Pharmaceuticals and Medical Devices Agency] and the MHLW [Mōrōshō – Ministry of Health, Labour and Welfare]. | Patient advocacy
> Patient advocacy | Regulatory partnership
> Participate in Health Technology Assessment (HTA) and reimbursement reviews | 100 | National | Sometimes | 119036459439 |
| Towards the approval of molecularly targeted therapies. | Cancer
> Cancer: lung | Regulatory partnership
> Contribute to Marketing Authorisation submissions | 1,000 | Regional | Rarely | 119053044699 |
| We submit a formal petition to the [Japanese] Ministry of Health, Labour and Welfare (MHLW) once a year and conduct a follow-up meeting. | Transplants
> Transplants: most | Regulatory partnership
> Attend/facilitate meetings with policymakers/regulators | 100 | National | Regularly | 119051955551 |
| I participate in petition campaigns through the National Psoriasis Patients Federation. | Skin
> Psoriasis | Regulatory partnership
> With other healthcare advocates | 100 | Regional | Rarely | 119013683256 |
| Every year, we submit budget requests for the following fiscal year to the national government and prefectural governments. | Liver
> Liver diseases: most types | Impacting policy and legislation
> Influence healthcare policy and legislation | 5,000 | National | Regularly | 119036457777 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | Infectious
> Infectious disease: other | Impacting policy and legislation
> Participate in public hearings and consultations | 100 | National | Sometimes | 119035140720 |
| We submit a formal written petition to the MHLW [Mōsō Rōdōshō – Ministry of Health, Labour and Welfare] once a year. | Transplants
> Transplants: most | Impacting policy and legislation
> Participate in public hearings and consultations | 100 | National | Regularly | 119051955551 |
| Once a year, the organisation submits its formal requests at the opinion exchange forum held jointly with the prefectural and municipal authorities. | Rheumatic
> Rheumatic diseases: other | Impacting policy and legislation
> Participate in public hearings and consultations | 100 | National | Regularly | 119078001121 |
| Visited the House of Representatives members' office building and held a meeting with a member of parliament. | Rheumatic
> Rheumatic diseases: most types | Impacting policy and legislation
> Mobilise parliamentarians and political leaders | 1,000 | National | Rarely | 119014930939 |
| Submission of a written petition to the Minister of Health, Labour and Welfare. | Endocrine
> Diabetes: type 1 | Impacting policy and legislation
> Mobilise parliamentarians and political leaders | 100,000 | National | Regularly | 119019815441 |
| Expedited approval of stem cell-based regenerative medicine products. | Rare
> Rare diseases: EB | Impacting policy and legislation
> Addressing barriers/anomalies in medical care | 1,000 | National | Sometimes | 119077906981 |
| Early approval of new medicines, resolution of drug lag and drug loss, and applications based on established medical knowledge. | Cancer
> Cancer: pancreatic | Impacting policy and legislation
> Addressing barriers/anomalies in medical care | 10,000 | National | Regularly | 119079604807 |
| Insurance reimbursement coverage for Pegasys [peginterferon alfa-2a, used to treat chronic hepatitis B and C, as well as rare cancers]. | Cancer
> Cancer: blood | Pricing and affordability advocacy
> Advocating for inclusion of product in reimbursement lists/national formularies | 1,000 | National | Regularly | 119014697897 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | Infectious
> Infectious disease: other | Pricing and affordability advocacy
> Engaging in awareness campaigns | 100 | National | Sometimes | 119035140720 |
| A request for greater disease awareness. | Not Specified
> Not specified | Pricing and affordability advocacy
> Engaging in awareness campaigns | 100 | National | Regularly | 119061457501 |
| Towards the approval of molecularly targeted therapies [for lung cancer]. | Cancer
> Cancer: lung | Improving access pathways
> Facilitate equitable access to medicines/healthcare | 1,000 | Regional | Rarely | 119053044699 |
| Key advocacy priorities include: accelerated approval pathways for new medicines, resolution of drug lag and drug loss issues, and the known-use application process (applications for medicines already recognised in the scientific literature or approved in other jurisdictions). | Cancer
> Cancer: pancreatic | Improving access pathways
> Facilitate equitable access to medicines/healthcare | 10,000 | National | Regularly | 119079604807 |
| We have organised vaccine awareness marches and submitted formal written requests to the Kōrōshō [厚生労働省 – Ministry of Health, Labour and Welfare]. | Infectious
> Infectious disease: other | Improving access pathways
> Advocate for wider vaccine access | 100 | National | Sometimes | 119035140720 |
| Insurance reimbursement coverage for Pegasys [peginterferon alfa-2a, used to treat chronic hepatitis B and C, as well as rare cancers]. | Cancer
> Cancer: blood | Improving access pathways
> Improving access to rare/ultra-rare therapies | 1,000 | National | Regularly | 119014697897 |
| Expedited approval of stem cell-based regenerative medicine products. | Rare
> Rare diseases: EB | Improving access pathways
> Improving access to rare/ultra-rare therapies | 1,000 | National | Sometimes | 119077906981 |
| The Ministry of Health, Labour and Welfare; the Medical Insurance Subcommittee of the Social Security Council; and related bodies. | Allergy
> Allergy | Institutional governance
> Ensure representation within governmental advisory bodies | 100,000 | National | Sometimes | 119078144899 |
interactions
actions & advocacy
4 mentions
